Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026: Our ...

The rise of China and India, combined with protectionist pressure from the Trump administration, is redrawing the global map ...

Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...

Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...

The year 2025 was defined by escalating global trade tensions that fundamentally reshaped the pharmaceutical supply chain, ...

On the back of several strong quarters and a year already chock-full of manufacturing accords, Korean CDMO Samsung Biologics is adding yet another project to its contract manufacturing Rolodex.

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...

Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making ...

Halo Pharma is expanding manufacturing capacity at its Whippany, NJ, facility with the addition of a Gerteis Macro-Pactor.

Preclinical research is crucial for the development of any novel drug. It demands significant resources that are often expensive and inaccessible to biotechnology and pharmaceutical companies of all ...

Sun Pharma highlights obesity treatment drugs as a growth driver for India's pharma industry, enhancing access to GLP-1 ...

Its unwavering commitment to quality, combined with our streamlined production methods, has led to outstanding results as we work together to address the country’s public health needs." Kamran Butt, ...